FDA Details Structure Of Drugmakers' Pediatric Study Plans
The U.S. Food and Drug Administration on Friday described how drugmakers can comply with a new requirement that they detail their plans for studying new medicines in children at an early...To view the full article, register now.
Already a subscriber? Click here to view full article